SIRNA FOR INHIBITING THE EXPRESSION OF BHRF1 AND COMPOSITION COMPRISING SAME

摘要

The present invention relates to an siRNA which inhibits the expression of BHRF1 in the Epstein-Bar virus (EBV), and to a compound for inhibiting resistance to anticancer medications using the siRNA. More particularly, the present invention relates to an siRNA which inhibits the expression of BHRF1, and to a composition for inhibiting resistance to anticancer medications for the treatment of EBV-positive stomach cancer, comprising the siRNA. Further, the present invention relates to a composition for the treatment of EBV-positive stomach cancer, comprising the siRNA and the anti-cancer agent.